After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price ...

Read here for an update on Yacktman Asset Management's portfolio changes, top holdings, and performance compared to market ...

Canaccord Genuity analysts downgraded Intra-Cellular Therapies (NASDAQ:ITCI) stock from Buy to Hold, adjusting the price target to $132 from the previous $119. The revision follows the recent ...

Oppenheimer launched its coverage of Alumis (NASDAQ:ALMS) with an Outperform recommendation and a 12–18-month price target of ...

As of 10:23:25 AM EST. Market Open. Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we ...

Sustainability data is currently not available for CR.

At close: January 28 at 4:00:00 p.m. EST ...